Key result
Chemotherapy resolves ALK-positive ALCL and splenic venous tumor thrombosis in a single case.
Why the study?
Lymphoma rarely infiltrates vascular structures, and cases of ALK-positive ALCL with tumor thrombosis are uncommon and not well characterized.
Case Report (n=1)
Lymphoma should be considered in the differential diagnosis of malignancies presenting with tumor thrombosis.
Supports including lymphoma in tumor thrombosis differential; hypothesis-generating for chemotherapy response in rare ALK-positive ALCL.
Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL) is a T cell subtype of non-Hodgkin's lymphoma (NHL). Typically, lymphoma rarely infiltrates vascular structure. In this article, we present a case of retroperitoneal ALK-positive ALCL with splenic venous tumor thrombosis. A 62-year-old patient presented to our institute with the symptoms of epigastric pain, abdominal distension, and reduced bowel movement. Physical examination indicated no enlarged peripheral lymph nodes or abdominal mass. Laboratory workup revealed granulocytosis, abnormal coagulation function, and normal level of lactic dehydrogenase (LDH). Contrast-enhanced computed tomography (CT) showed a retroperitoneal mass with involvement of pancreas and duodenum and formation of splenic venous tumor thrombus. Ultrasonography-guided retroperitoneal lesion biopsy confirmed the diagnosis of ALK-positive ALCL. The patient was able to tolerate oral intake after two cycles of chemotherapy and showed no sign of lymphoma by positron emission tomography (PET)-CT after the fourth cycle of chemotherapy. In spite of its rarity, lymphoma should be taken into account as a differential diagnosis of other malignancies with tumor thrombosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) conducted a case report in Retroperitoneal ALK-positive anaplastic large cell lymphoma with splenic venous tumor thrombosis (n=1). Chemotherapy was evaluated on Clinical and radiological response. Chemotherapy led to no sign of lymphoma on PET-CT after four cycles in a 62-year-old patient with retroperitoneal ALK-positive ALCL and splenic venous tumor thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: